HER2 positivity in gastric cancer ranges from as low as 4% to as high as 53% (Kunz et al., 2012; Shan et al., 2013; Abrahao-Machad et al., 2016; Gharsalli et al., 2017). This evidence concerns the gene ERBB2 and gastric cancer.